AMCP Update: FDA Preapproval Information Exchange
Webinar Recorded on Oct. 30, 2018
Payors have indicated interest in receiving information from manufacturers about medical products that are not yet approved/cleared by the FDA for any use, and about unapproved uses of approved/ cleared medical products. This information may allow payors to plan and budget for future coverage and reimbursement decisions prior to FDA approval.
FDA provided final guidance on Pharmaceutical Information Exchange in June 2018. AMCP has been involved throughout the process- advocating, presenting and supporting members’ needs, as well as providing communication to both members and manufacturers.
This webinar will provide an overview the
Want to read the full content? Please sign in or become a member to access this content.